Clinical Trial Update: Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study [Phase 2]

View source ↗

Summary

Phase 2 Asia efficacy study of a Traveler's diarrhea vaccine by Intercell USA, Inc. has completed; this is a status update on the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• Traveler's diarrhea vaccine

Snippet

Sponsor: Intercell USA, Inc. | Conditions: Traveler's Diarrhea | Phase 2 | Status: COMPLETED